in conclusion metagenome analysis was useful for rapid bacterial diagnostics including assessing potential antimicrobial susceptibility in patients with ac.keywords acute cholecystitis metagenome analysis next-generation sequencing bacteriological analysis gut microbiotaintroductionacute cholecystitis ac is the acute inflammation of the gallbladder.

doi huson d. h. auch a. f. qi j. and schuster s. c. 2007. megan analysis of metagenomic data.

2015. currently there are no reports regarding the use of a metagenomic approach to reveal comprehensive microbiota analysis of patients with ac.metagenome analysis by next-generation dna sequencing ngs has led to a new method of identifying the etiological agents of an infectious disease tang and chiu 2010 chan et al.

for the case of bactibilia the metagenome analysis results were consistent with those of conventional culture examination and antimicrobial susceptibility testing.a greater number of esbl-positive e. coli ngs reads were detected by metagenome analysis in p1 and p4 compared with that in other patients.

8685. doi abbreviations ac acute cholecystitis ercp endoscopic retrograde cholangiopancreatography esbls extended-spectrum ss-lactamase ibd inflammatory bowel disease mlst multilocus sequence typing na not applicable ngs next-generation sequencing tg13 tokyo guidelines 2013.takada et al.

19 476-486. doi banerjee r. and johnson j. r. 2014. a new clone sweeps clean the enigmatic emergence of escherichia coli sequence type 131. antimicrob.

58 4997-5004. doi barzon l. lavezzo e. militello v. toppo s. and palu g. 2011. applications of next-generation sequencing technologies to diagnostic virology.

12 7861-7884. doi becker c. neurath m. f. and wirtz s. 2015. the intestinal microbiota in inflammatory bowel disease.

56 192-204. doi bonnet r. 2004. growing group of extended-spectrum b-lactamases the ctx-m enzymes.

48 1-14. doi chan j. z. pallen m. j. oppenheim b. and constantinidou c. 2012. genome sequencing in clinical microbiology.

30 1068-1071. doi clemente j. c. ursell l. k. parfrey l. w. and knight r. 2012. the impact of the gut microbiota on human health an integrative view.

cell 148 1258-1270. doi clinical and laboratory standards institute 2012. performance standards for antimicrobial susceptibility testing twenty-second informational supplement.

131 389-394. doi dalal s. r. and chang e. b.

124 4190-4196. doi faria n. r. azevedo rdo s. kraemer m. u. souza r. cunha m. s. hill s. c. et al.

science 352 345-349. doi frank d. n. st. amand a. l. feldman r. a. boedeker e. c. harpaz n. and pace n. r. 2007. molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

